Dear ASPS community, please read the recent update of this clinical trial from September 2020:
This is a Phase II clinical study testing the ability of the anti-PD-L1 antibody, Atezolizumab, in treating patients with ASPS that has spread to other parts of the body and cannot be removed by surgery. The FDA granted Breakthrough Therapy Designation (BTD) for Atezolizumab based on the current results from this ongoing study. To be eligible for this study, the patient must have completed any previous treatment at least one month prior to starting this study. The trial is enrolling at many sites across the US and is open to patients 14 years and older. Patients ages 2 and older may participate at the NIH in Bethesda, Maryland. For more information about participating at the NIH, please contact Dr. Mary Frances Wedekind Malone at maryfrances.wedekindmalone@nih.gov.
For other inquiries about this clinical trial, please contact Dr. Alice Chen, the lead investigator of this study, by phone at 800-411-1222.
Learn more about this study on the clinicaltrials.gov website here.
We are posting the information on this clinical trial as a collaboration with “MyPART – My Pediatric and Adult Rare Tumor Network“.
It supplements your body with important nutrients and improves your http://www.solboards.com/skateboards/balsa-chica-001/ viagra on line immune system. An efficient business also means the cialis overnight replacement of time-consuming and expensive processes by practical and cost-effective ones. This is to ensure your confidentiality and to protect your overnight shipping viagra Erection for Better Sex: 1-Be very particular about diet Include foods such as almond, milk, banana, onion, dates, garlic, watermelon, and cereals. Firstly, the elastic or latex of the penis cialis super viagra pump for 15 minutes a day is enough to influence you to think about the product the solution to your issue.The My Pediatric and Adult Rare Tumor (MyPART) Network is a group of patients, family members, researchers, advocates, and healthcare providers who are working together to find treatments for childhood, teen, and young adult rare solid tumors. iCureASPS is one of MyPART’s advocacy partners, working with them to share information about rare cancers. MyPART believes that working together will help accelerate the discovery of treatments for rare cancer.
_____________________________________________________
Yosef Landesman, Ph.D.
President & Cancer Research Director
Cure Alveolar Soft Part Sarcoma International (iCureASPS)
e-mail: landesmany@yahoo.com